Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02818322
Other study ID # PA15083
Secondary ID
Status Recruiting
Phase N/A
First received June 23, 2016
Last updated June 27, 2016
Start date April 2016
Est. completion date October 2018

Study information

Verified date June 2016
Source CHU de Reims
Contact Maud FRANCOIS
Email mfrancois@chu-reims.fr
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The role of telemedical monitoring in diabetic foot care is still uncertain. The aim is to compare telemedical + standard and standard alone outpatient monitoring in the care of patients with diabetic foot ulcers in a randomized controlled trial. The primary outcome of the overall study is the time of ulcer healing. The number of amputation, hospital admissions and surgical procedure will be also reported. Investigators hope to include 150 patients in this study.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date October 2018
Est. primary completion date October 2018
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patients treated in the diabetology department of CHU de Reims during the inclusion phase to a diabetic foot lesions ( infected or not).

- Patients with care of this lesion of diabetic foot externally.

- Patients who agreed to participate in or accepting ORNICARE network ( network for the transmission of information between health care professionals) (Appendix 3) .

- Patients aged over 18 years .

- Patients who agreed to participate in the study .

- The patients insured by a social security scheme .

Exclusion Criteria:

- Patients requiring hospital care of the lesion of diabetic foot (infection requiring surgical intervention , ischemia requiring revascularization , ...).

- Patients are protected by law .

- Minor patients.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Device:
telemedical monitoring ( T)

classic monitoring


Locations

Country Name City State
France Chu de Reims Reims

Sponsors (1)

Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary time of ulcer healing 6 month after inclusion No